(Q37825664)

23 August 2017

1 reference

title

Hepatocyte growth factor twenty years on: Much more than a growth factor (English)

1 reference

23 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21199531

21 November 2024

signal transduction

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21199531

21 November 2024

Katsuya Sakai

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21199531

21 November 2024

Kunio Matsumoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21199531

21 November 2024

Takahiro Nakamura

1 reference

23 August 2017

Toshikazu Nakamura

series ordinal

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21199531

21 November 2024

publication date

1 January 2011

1 reference

23 August 2017

January 2011

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21199531

full work available at URL

21 November 2024

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1440-1746.2010.06549.x

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21199531

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1440-1746.2010.06549.x

21 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1440-1746.2010.06549.x

21 November 2024

1 reference

DOI

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Journal of Gastroenterology and Hepatology

21 November 2024

published in

1 reference

23 August 2017

volume

26 Suppl 1

1 reference

23 August 2017

page(s)

188-202

1 reference

Emerging multipotent aspects of hepatocyte growth factor

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Growth inhibition and apoptosis in liver myofibroblasts promoted by hepatocyte growth factor leads to resolution from liver cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

Anti-cancer approach with NK4: Bivalent action and mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2010.06549.X

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.1141478

Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Partial characterization of a hepatocyte growth factor from rat platelets

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Purification and subunit structure of hepatocyte growth factor from rat platelets

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Molecular cloning and expression of human hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor: Molecular structure and implications for a central role in liver regeneration

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Tumor cytotoxic factor/hepatocyte growth factor from human fibroblasts: cloning of its cDNA, purification and characterization of recombinant protein

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Scatter factor/hepatocyte growth factor is essential for liver development

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Crystal structure of the NK1 fragment of human hepatocyte growth factor at 2.0 A resolution

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Crystal structure of the NK1 fragment of HGF/SF suggests a novel mode for growth factor dimerization and receptor binding

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor may accelerate healing in chronic leg ulcers: a pilot study.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Crystal structure of the HGF beta-chain in complex with the Sema domain of the Met receptor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor, a versatile signal for developing neurons

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor/scatter factor is an axonal chemoattractant and a neurotrophic factor for spinal motor neurons

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor (HGF) promotes oligodendrocyte progenitor cell proliferation and inhibits its differentiation during postnatal development in the rat

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor/c-met signaling pathway is required for efficient liver regeneration and repair

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Met provides essential signals for liver regeneration

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Deletion of the Met receptor in the collecting duct decreases renal repair following ureteral obstruction

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor signaling ameliorates podocyte injury and proteinuria

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

c-Met is essential for wound healing in the skin

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocarcinogenesis in mice with a conditional knockout of the hepatocyte growth factor receptor c-Met

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor activator (HGFA): a serine protease that links tissue injury to activation of hepatocyte growth factor.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor activator (HGFA): pathophysiological functions in vivo

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Defect of pro-hepatocyte growth factor activation by fibroblasts in idiopathic pulmonary fibrosis

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor favors monocyte differentiation into regulatory interleukin (IL)-10++IL-12low/neg accessory cells with dendritic-cell features

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Essential role of Gab1 for signaling by the c-Met receptor in vivo

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Bi-directional regulation of Ser-985 phosphorylation of c-met via protein kinase C and protein phosphatase 2A involves c-Met activation and cellular responsiveness to hepatocyte growth factor.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Cooperative interaction between alpha- and beta-chains of hepatocyte growth factor on c-Met receptor confers ligand-induced receptor tyrosine phosphorylation and multiple biological responses.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Structural characterization of autoinhibited c-Met kinase produced by coexpression in bacteria with phosphatase

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Activating mutations for the Met tyrosine kinase receptor in human cancer

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

MET as a target for treatment of chest tumors

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Drug development of MET inhibitors: targeting oncogene addiction and expedience

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

The MET axis as a therapeutic target

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

HGF/NK4 is a specific antagonist for pleiotrophic actions of hepatocyte growth factor

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor-activating mutations.

21 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1440-1746.2010.06549.X

21 November 2024

Identifiers

DOI

1 reference

23 August 2017

1 reference